NKE
28
-2
INTC
41
5
OI
28
3
AVGO
25
-2
DAL
77
-3
UNH
50
-5
WAT
66
2
KR
38
-2
ORLY
57
3
ESS
51
4
MMM
28
-2
OXY
53
4
GPC
29
7
LNC
39
-6
EQR
44
7
TJX
42
-9
CFG
52
-2
ETR
63
-3
USB
44
-2
XYL
35
2
NKE
28
-2
INTC
41
5
OI
28
3
AVGO
25
-2
DAL
77
-3
UNH
50
-5
WAT
66
2
KR
38
-2
ORLY
57
3
ESS
51
4
MMM
28
-2
OXY
53
4
GPC
29
7
LNC
39
-6
EQR
44
7
TJX
42
-9
CFG
52
-2
ETR
63
-3
USB
44
-2
XYL
35
2
Financhill
Back

Ocular Therapeutix 10K Form

Buy
54

OCUL
Ocular Therapeutix

Last Price:
10.24
Seasonality Move:
21.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OCUL News And Ratings

See the #1 stock for the next 7 days that we like better than OCUL

OCUL Financial Statistics

Sales & Book Value

Annual Sales: $58.44M
Cash Flow: $-25.54M
Price / Cash Flow: 0
Annual Sales: $2.43
Price / Book: 4.24

Profitability

EPS (TTM): -1.35000
Net Income (TTM): $-138.36M
Gross Margin: $53.16M
Return on Equity: -77.93%
Return on Assets: -43.43%

Ocular Therapeutix Earnings Forecast

Key Ocular Therapeutix Financial Ratios

  • The Gross Profit Margin over the past 12 years for OCUL is 90.96%.
  • The Selling, General & Administrative Expenses for OCUL have been equal to 127.46% of Gross Profit Margin.
  • The Research & Development expenses have been 104.47% of Revenue.
  • The Interest Expense is -14.04% of Operating Income.
  • The Net Earning history of OCUL is -138.14% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Ocular Therapeutix Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OCUL
CUSIP: 67576A
Website: ocutx.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 16.64
Quick Ratio: 16.35

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OCUL Technical Analysis vs Fundamental Analysis

Buy
54
Ocular Therapeutix (OCUL) is a Buy

Is Ocular Therapeutix a Buy or a Sell?